Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Delta Expands Seattle-Tokyo Network With New Narita Service
Delta Expands Seattle-Tokyo Network With New Narita Service

Delta Air Lines’ DAL launch of daily nonstop service between Seattle and Tokyo-Narita, beginning March 27, 2027, is expected to strengthen its position in the Pacific Northwest and expand

Here's How Ross Stores Stock is Poised Ahead of Q2 Earnings
Here's How Ross Stores Stock is Poised Ahead of Q2 Earnings

Ross Stores, Inc. ROST is likely to post year-over-year top and bottom-line growth when it reports second-quarter fiscal 2026 earnings on Aug. 20, after market close. The Zacks Consensus Estimate

Accelerant Q2 Earnings Beat Estimates on Strong Premium Growth
Accelerant Q2 Earnings Beat Estimates on Strong Premium Growth

Accelerant Holdings ARX reported second-quarter fiscal 2026 adjusted earnings of 32 cents per share, which more than doubled from 13 cents reported in the year-ago quarter. The bottom line beat the

Intellicheck Mobilisa, Inc. (IDN) Matches Q2 Earnings Estimates
Intellicheck Mobilisa, Inc. (IDN) Matches Q2 Earnings Estimates

Intellicheck Mobilisa, Inc. (IDN) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $0.01 per share a year ago. These

WidePoint (WYY) Q2 Earnings Meet Estimates
WidePoint (WYY) Q2 Earnings Meet Estimates

WidePoint (WYY) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $0.06 per share a year ago. These figures are adjusted for

4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates
4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates

4D Molecular Therapeutics, Inc. (FDMT) came out with a quarterly loss of $1.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.98 per share a year ago. These